Interpace Biosciences Inc.

29/07/2024 | Press release | Distributed by Public on 29/07/2024 12:29

Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.